RAC 4.92% $1.45 race oncology ltd

Yes, as an investor, I believe it was one of the few options...

  1. 139 Posts.
    lightbulb Created with Sketch. 33
    Yes, as an investor, I believe it was one of the few options available best at the time. Had DCB not changed the strategy with poor clinical proposals then it would not have been necessary but unfortunately it appeared that JC bent his ear. If you understood the dynamics at the time you might see the rationale, that is of course, unless your purpose is to just throw mud...
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.